Autologous hematopoeitic stem cells and mesenchymal stem cells transduced with lentiviral vector carrying the FANCA gene ex vivo
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2017 (NCT03351868)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03351829 | N/A | Dec 1, 2017 | Shenzhen Geno-Immune Medical Institute |
| NCT03351868 | N/A | Dec 1, 2017 | Capital Medical University, Shenzhen Geno-Immune Medical Institute |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shenzhen Geno-Immune Medical Institute | Academic/Hospital | 2 | 2 | 1 | 2017 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1